Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
EIKN compared with AKTS: revenue, margins and what each company keeps, and the suppliers and customers both name
EIKN
Eikon Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
AKTS
Aktis Oncology, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
EIKN
Eikon Therapeutics, Inc.
vs
AKTS
Aktis Oncology, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
EIKN, solid
AKTS, dashed
EIKN
Eikon Therapeutics, Inc.
Change
5.68
· pre 5.60
· delayed
Mkt cap
$287.5M
Revenue
—
AKTS
Aktis Oncology, Inc.
Change
14.58
· pre 14.59
· delayed
Pre-market
Nov 2 '26
delayed
Mkt cap
$806.8M
Revenue
$3M
Q2 FY26
vs
Compare
Pre-market
Nov 2 '26
delayed
EIKN
Eikon Therapeutics, Inc.
vs
AKTS
Aktis Oncology, Inc.
5.68
pre 5.60
delayed
Price
14.58
pre 14.59
delayed
$287.5M
Mkt cap
$806.8M
—
Revenue
$3M
Q2 FY26
Change
Change
EIKN
5.68
vs
AKTS
14.58
Pre-market
Nov 2 '26
delayed